Dr. Noura Abul-Husn Receives the 2021 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic and Genomic Medicine

April 13, 2021

Mount Sinai Launches New Center for Artificial Intelligence

The center is the first in New York to integrate artificial intelligence, genomics, and data science to advance clinical care

June 11, 2019

Genes of human “mutants” point to a new superpower

DNA search finds people resistant to liver disease. Can we mimic the effect with a drug?

March 21, 2018

“That would be our hope, that we could create a drug that targets this and that either prevents the progression of liver disease, which we think would be possible, or could treat some stages of liver disease before it becomes too late.”


Top 10 under 40

May 22, 2017

Top 40 under 40

May 2, 2017

Hypercholesterolemia: Underdiagnosed, undertreated

“Being able to connect patient’s de-identified medical records with their DNA data is an advantage that few others in this field have. Paired with the RGC’s unique technological and analytical resources, we are able to make meaningful discoveries that may advance the implementation of precision medicine today and the development of new or improved medicines tomorrow,” said Noura Abul-Husn, M.D., Ph.D.

December 22, 2016

FH and other findings from Geisinger-Regeneron genomics studies

December 22, 2016